ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,036.88
-0.17%
US Tech 100
20,622.40
0.05%
다우존스 지수
44,644.43
-0.31%
Bitcoin
94,958.37
-0.94%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Shield Therapeutics Plc (STX) 시세

Shield Therapeutics Plc

Shield Therapeutics Plc (STX)

Strike Energy Limited
Starrex International Ltd
Seagate Technology Holdings PLC
2.85
0.00
(0.00%)
마감 04 12월 1:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
2.85
매수가
2.80
매도가
2.90
거래량
1,516,809
2.75 일간 변동폭 2.85
1.075 52주 범위 7.65
market_cap
22.1M
전일 종가
2.85
개장가
2.75
최근 거래 시간
60000
@
2.82
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
3,080,998
발행 주식
775,429,360
배당수익률
-
주가수익률
-0.66
주당순이익(EPS)
-0.04
매출
13.09M
순이익
-33.29M

Shield Therapeutics Plc 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.shieldtherapeutics.com
본부
Newcastle Upon Tyne, Gbr
설립됨
-
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker STX. The last closing price for Shield Therapeutics was 2.85p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 7.65p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £22.10 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.66.

STX 최신 뉴스

추가 뉴스

Shield Therapeutics shares up on strong October sales

Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following ...

21 11월 2024
Alliance News

Shield Therapeutics PLC Business Update

Shield Therapeutics PLC 21 November 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Business Update Recruitment completed of the Phase 3 confirmatory Study in...

21 11월 2024
RNS Regulatory News

Shield Therapeutics shares slide as it expands financing arrangement

Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flo ...

29 10월 2024
Alliance News

Shield Therapeutics PLC Q3 Trading Update

Shield Therapeutics PLC 29 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

29 10월 2024
RNS Regulatory News

Shield Therapeutics PLC Results from Phase 3 paediatric study

Shield Therapeutics PLC 25 September 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Results from Phase 3 paediatric study   Pivotal Trial of ACCRUFeR®/FeRACCRU®...

25 9월 2024
RNS Regulatory News

Shield Therapeutics revenue triples, but cost rises widen annual loss

Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales a ...

04 9월 2024
Alliance News

Shield Therapeutics PLC Interim results

Shield Therapeutics PLC 04 September 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Interim results for the six months ended 30 June 2024   More than threefold...

04 9월 2024
RNS Regulatory News

TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

28 8월 2024
Alliance News

Shield Therapeutics PLC ACCRUFeR® Approved by Health Canada

Shield Therapeutics PLC 27 August 2024     Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   ACCRUFeR® Approved by Health Canada   ACCRUFeR® is the only oral iron therapy...

27 8월 2024
RNS Regulatory News

Shield Therapeutics PLC Notice of interim results

Shield Therapeutics PLC 14 August 2024   Shield Therapeutics plc ("Shield" or the "Company" or the "Group")   Notice of interim results   London, UK, 14 August 2024: Shield Therapeutics plc...

14 8월 2024
RNS Regulatory News
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1002.852.92.754379692.87099896DE
40.051.785714285712.83.352.62533782192.87233311DE
12-2.25-44.11764705885.15.12.62530809983.60349314DE
260.839.02439024392.055.81.52538615333.38871876DE
52-3.45-54.76190476196.37.651.07543580823.15881968DE
156-29.65-91.230769230832.5511.07525618335.92014453DE
260-190.15-98.52331606221931951.075180763913.77024522DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SCGLSealand Capital Galaxy Limited
0.54p
(80.00%)
30.47M
OBDOxford Biodynamics Plc
2.11p
(55.15%)
7.97M
MIRIMirriad Advertising Plc
0.18p
(33.33%)
23.04M
CLCOCloudcoco Group Plc
0.26p
(30.00%)
3.42M
IESInvinity Energy Systems Plc
15.00p
(27.66%)
4.57M
ZNTZentra Group Plc
3.50p
(-36.36%)
221.85k
UOGUnited Oil & Gas Plc
0.125p
(-34.21%)
123.45M
SYSSysgroup Plc
21.50p
(-24.56%)
788.98k
ADAAdams Plc
3.50p
(-22.22%)
25k
DSMDowning Strategic Micro-cap Investment Trust Plc
3.70p
(-21.28%)
22.32k
ORCPOracle Power Plc
0.0525p
(-7.89%)
3.56B
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.51B
SYMESupply@me Capital Plc
0.0031p
(-10.14%)
1.11B
ENETEthernity Networks Ltd
0.1425p
(18.75%)
547.92M
KEFIKefi Gold And Copper Plc
0.524p
(-19.63%)
546.94M

토론

전체 피드 보기
Slojab Slojab 3 분 전
What would I do? I'd lament my stupidity every day.

And yes, hope for a miracle. Because with Frank's OTC history of failure and a pending R/S, that's what it would take.

The real question should be, would I buy this ticker now at $.0001. The answer is no.
SANP
sissyjane1 sissyjane1 3 분 전
I think most of us understand the pros and cons of AI and the pit falls that can be had , I am glad WM has pointed out the RJ factor and what its worth , the misleading it led to but what I think is we need to get past the RJ bs and get back to the true DD we need for moni ...just my little brain s
MONI
Jetmek_03052 Jetmek_03052 3 분 전
Poo CANNOT form a valid answer as to WHY Linda has never appointed an Independant director to the Board of Directors or the Audit Committee since coming back to the Pink level.

The rules are CRYSTAL CLEAR as to the governance needed to be able to get to the QB level.

T
DBMM
RSI38 RSI38 3 분 전
Obviously both of us are NOT surprised by this good morning sir

Keep up the good work
MATT


PLYZ

RSI38 APPROVED
PLYZ
ducci1 ducci1 4 분 전
Intraday 5 min Falling Triangles---ES Base 6047----SPX Base 6033 ! Trade the Breaks !!
SPY
JRoon71 JRoon71 4 분 전
North, I think you may be right.

And if you look at their verbiage on China, they only stated that Edding is "advancing efforts" for reimbursement in China. There was no mention of potential inclusion this year. Since NRDL negotiations were essentially completed when they made their p
AMRN
zab zab 4 분 전
https://apnews.com/article/south-korea-yoon-martial-law-997c22ac93f6a9bece68454597e577c1

Shit happening all over the world, so who will Trump align himself, Russia and North Horea, and the rest of his right-wing maniacs.
SmellMyFinger SmellMyFinger 4 분 전
Interesting, although hard to fully understand based on how the news is worded. Time will tell if this does in fact increase shareholder value™ or if this stock remains stuck in the lower trips.
HMBL
JustJack JustJack 4 분 전
Hey fella, or lady or they, them, you with the brown uniform that says UPS on it, wait until I contact the owner and he approves you coming near those other Amazon packages. It should only take a minute or five. If you leave the alarm will go off.

UPS driver. "I will never leave a pac
AITX
Flyingj Flyingj 4 분 전
Just curious. If mrkr is successful advancing there therapy, what will it take for patients to bypass car-t all together and go straight to markers therapy?
MRKR
taketobank taketobank 5 분 전
yes. I also remember him mentioning Amazon as an example of a possibility. Not sure if that is a great idea due to the potential of 'fake' anavex being sold online. jmo
AVXL
Big Momma Big Momma 5 분 전
Big Fun META Christmas Party!
META
PumpersExposed PumpersExposed 5 분 전
Yup.. exactly.. Like my buddy who ran major projects for western canada for TCPL said back when QSEP somehow got a deal to test on their line, "if this worked we would have already had it".
QSEP
HoldEm777 HoldEm777 5 분 전
OTCN still in the box owning the ASK
RDAR
learningcurve2020 learningcurve2020 5 분 전
Yeah, skull and crossbones / thumbs down.  If you're a legit shareholder that makes no sense whatsoever. 
NWBO
gitreal gitreal 5 분 전
paid short manipulation.

Baloney. Nobody's shorting SDRC.

Engaging in idiotic conspiracies about Shorty, corrupt MM's, air shares, etc. is not "Real DD".
SDRC
zab zab 5 분 전
https://www.france24.com/en/france/20241202-why-the-french-government-is-headed-for-collapse

I cannot wait till Trump gets into office and starts dismantling America.
delerious1 delerious1 6 분 전
OTC PINK:RONN Ronn Inc. Ceo Invited to Attend and Speak About the Global Hydrogen Future at the World Economic Forum as Member of the Monaco Delegation in January 2025
Tuesday, 03 December 2024 09:00 AM

ACCESSWIRE | Article Logo
RONN


Company Upda
johnydollar johnydollar 6 분 전
2025 is coming fast and loud........
DBMM
GoldDog83 GoldDog83 6 분 전
Why the sell off here?
AMTX
ddls ddls 6 분 전
I already looked at that and knew you would be right behind me. 🤠

Of course it's ALL about posts, right?

This company is still a piece of junk no matter how you slice it.
BIEL
north40000 north40000 6 분 전
Agree with 2025. Application for review was filed a few day(s) late to be considered in 2024 from my reading weeks ago.
AMRN
JRoon71 JRoon71 6 분 전
Based on their presentation a few weeks ago, I would expect approval in Italy by year-end. They were pretty clear that they no longer want to commit resources to countries where they do not see a current path to reimbursement. This is why there is nobody in France and Germany currently.
AMRN

최근 히스토리

LSE
STX
Shield Therapeutics
LSE
0MTN
Source Stoxx Europe 600 ...
NASDAQ
ADUR
Aduro Clean Technologies
BITMOT
970502
Btp Tf 4,5% Ot53 Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유